The cryopreservation for the in-vitro fertilization market is expected to register a valuation of USD 461.4 million in 2023. The market is anticipated to rise to USD 1,264.9 million by 2033. The market is likely to record a CAGR of 10.6% during the forecast period.
Cryopreservation, or freezing and storing biological samples, is an essential technique in the in-vitro fertilization (IVF) field. Here are a few of the driving factors that are fueling the market growth are:
Increasing demand for IVF: A rise in couples seeking fertility treatments due to a variety of reasons, including delayed parenthood and medical conditions. It has led to an increase in the demand for IVF, which has boosted the demand for cryopreservation.
Technological advancements: Advances in cryopreservation technology have made it possible to store and preserve embryos and other biological samples with greater efficiency and success rates. It has made IVF a more viable and accessible option for couples struggling with infertility.
Rising awareness: Increased awareness about the benefits of cryopreservation has contributed to its growing popularity. More couples are choosing to freeze their embryos for future use, especially if they have excess embryos after IVF treatment.
Legal and ethical concerns: The ethical and legal concerns surrounding the use of embryos have led to more countries allowing the freezing of embryos for later use. It has further boosted the demand for cryopreservation for IVF.
Increasing disposable income: The increasing disposable income of people in developed countries has made IVF and cryopreservation more affordable, contributing to the market's growth.
Overall, the market is expected to grow in the coming years as more couples seek fertility treatments and technological advancements continue to improve success rates.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The popularity of cryopreservation for in-vitro fertilization (IVF) is increasing among patients for several reasons:
Higher Success Rates: Cryopreservation technology has improved significantly over the years, resulting in higher success rates for IVF treatments using frozen embryos. Patients increasingly choose to freeze their embryos for future use because it increases the likelihood of a successful pregnancy.
Flexibility: Cryopreservation provides patients with greater flexibility in planning their fertility treatments. It allows couples to delay pregnancy until they are ready and enables patients to have multiple attempts at pregnancy using the same frozen embryos.
Reduced Costs: Cryopreservation can significantly reduce the cost of IVF treatment because patients do not have to undergo the entire IVF process each time they attempt to get pregnant. Instead, they can use their frozen embryos for future treatments, which can be less expensive.
Preservation of Fertility: Cryopreservation allows patients to preserve their fertility before undergoing medical treatments that could negatively affect their fertility, such as chemotherapy or radiation therapy.
Ethical Concerns: Some patients have ethical concerns about discarding unused embryos, and cryopreservation provides an alternative option that allows them to preserve their embryos for future use.
Overall, the growing popularity of cryopreservation for IVF can be attributed to its improved success rates, flexibility, cost-effectiveness, preservation of fertility, and ethical considerations.
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 10.6% |
| Market Valuation (2023) | USD 461.4 million |
| Market Valuation (2033) | USD 1,264.9 million |
The increasing demand for IVF treatments, advancements in cryopreservation technology, and rising awareness about the benefits of cryopreservation.
The market has shown steady growth in recent years, and the trend is expected to continue in the coming years. However, it is important to note that the COVID-19 pandemic may have impacted the market performance in 2020 and beyond.
Short Term (2023 to 2026): Increasing demand for fertility treatments, delayed parenthood, and related medical conditions drive market growth. For instance, in countries such as the United States, China, Germany, and the United States, the growing healthcare infrastructure is advancing the market size.
Medium Term (2026 to 2029): Increasing advanced technologies in the healthcare sector, rising awareness, and innovation of equipment are propelling market growth. For instance, in Canada, the healthcare infrastructure is widely growing due to the presence of key players during the forecast period.
Long Term (2028 to 2033): Increasing research & development activities, government supports, key market players and newly launched products are driving the market opportunities. The healthcare providers bring new advanced and budget-friendly treatments estimated to uplift the cryopreservation for in-vitro fertilization market size in coming years.
The market is estimated to capture a valuation of USD 1,264.9 million during the forecast period. Historically, the market registered a valuation of USD 415.9 million from 2017 to 2022.
Principal Consultant
In the global market, the product type category that highly influences the market is the cryopreservation media segment. Cryopreservation media are the solutions used to freeze and store biological samples, such as embryos, eggs, and sperm, in IVF procedures. The cryopreservation media is likely to capture a CAGR of 10.5% by 2033.
The cryopreservation media segment is expected to witness significant growth in the coming years. The increasing demand for IVF treatments, rising awareness about the benefits of cryopreservation, and technological advancements in cryopreservation media.
According to Future Market Insights report, the cryopreservation media segment to the increasing use of vitrification as a method of cryopreservation, which requires specialized media. Overall, the cryopreservation media segment is expected to be a key influencer in the global market due to its crucial role in the freezing and storing of biological samples. Historically, cryopreservation media registered a CAGR of 9.2% from 2018 to 2022.
The end-user category that dominates the global cryopreservation for the in-vitro fertilization market is fertility clinics. Fertility clinics are specialized healthcare facilities that offer infertility treatments, including IVF procedures, to couples having difficulty conceiving. The IVF & fertility clinics are expected to capture a CAGR of 9.9% by 2033.
The fertility clinics segment is expected to continue to lead the market share globally. The increasing prevalence of infertility and the availability of advanced fertility treatments in developed countries as key drivers of the segment's growth. Historically, IVF & fertility clinics registered a CAGR of 8.6% from 2018 to 2022.
The United States has been one of the leading markets for cryopreservation in-vitro fertilization (IVF) services. According to a report by Future Market Insights, the United States is likely to thrive at a CAGR of 11.2% with a valuation of USD 182.7 million by 2033.
The report attributes the strong performance of the United States market to several factors, including:
Increasing prevalence of infertility: The United States has one of the highest rates of infertility in the world, with around 1 in 8 couples experiencing difficulty conceiving. It has led to a growing demand for IVF and other fertility treatments, including cryopreservation.
Advanced healthcare infrastructure: The United States has a well-established healthcare infrastructure with advanced facilities and technologies. It has facilitated the development of advanced cryopreservation technologies and increased the availability of IVF and cryopreservation services.
Increasing adoption of single embryo transfer: The United States has seen a trend towards adopting single embryo transfer (SET) in IVF procedures, leading to an increased demand for cryopreservation services. Cryopreservation allows the storage of excess embryos for future use, thereby reducing the need for multiple rounds of IVF.
Supportive government policies: The United States has supportive government policies and regulations that promote the development and use of cryopreservation technologies for fertility treatments.
Overall, the increasing demand for fertility treatments and the availability of advanced healthcare infrastructure and technologies driving the market in the United States. Historically, the United States cryopreservation for the in-vitro fertilization market secured a CAGR of 9.9% between 2018 and 2022.
Germany has been a significant market for cryopreservation in-vitro fertilization (IVF) services. According to a report by Future Market Insights, Germany is expected to be one of the fast-growing markets in Europe during the forecast period. Germany is securing a CAGR of 11.6% with a valuation of USD 54.8 million by 2033.
Germany is known for its advanced healthcare infrastructure and is one of the leading countries in Europe regarding reproductive medicine. It has led to a thriving cryopreservation market for in-vitro fertilization (IVF) in Germany.
Cryopreservation is freezing and storing eggs, sperm, or embryos for later use in IVF. This technology has revolutionized the field of reproductive medicine, allowing couples to conceive even after years of infertility.
Germany has some of the most advanced IVF clinics in Europe, offering cutting-edge cryopreservation technologies. These clinics use state-of-the-art equipment and techniques to freeze and store eggs, sperm, and embryos, which can be used for IVF later.
Germany has a well-established legal framework that regulates IVF and cryopreservation. It gives patients confidence that the highest ethical and safety standards handle frozen eggs, sperm, or embryos.
Overall, Germany is expected to continue to be driven by the increasing demand for fertility treatments and supportive government policies. Historically, Germany cryopreservation for in-vitro fertilization market secured a CAGR of 10.1% between 2018 and 2022.
The United Kingdom is significantly growing the global market by capturing a CAGR of 11.0% with a valuation of USD 37 million by 2033. Growing healthcare infrastructure and strong research and development activities drive the United States cryopreservation for in-vitro fertilization market. While marketers play a role in promoting the benefits of cryopreservation, they are not the primary drivers of the market.
IVF clinics and healthcare providers in the United Kingdom are at the forefront of promoting cryopreservation as a viable option for couples who face fertility issues. These clinics offer advanced cryopreservation techniques and equipment, which have greatly improved the success rates of IVF procedures.
The United Kingdom has a strong research and development culture, with many universities and research institutions working on developing new technologies and techniques in the field of reproductive medicine. It has helped to advance the cryopreservation field, making it more accessible and effective for couples seeking IVF treatment.
While marketers may promote the benefits of cryopreservation through various channels, such as social media and advertising campaigns. The decision to undergo IVF treatment and cryopreservation ultimately lies with the patients and their healthcare providers.
The success of the cryopreservation market in the United Kingdom is primarily driven by the availability of advanced healthcare infrastructure and a supportive legal framework. Historically, the United States secured a CAGR of 9.7% between 2018 and 2022.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The cryopreservation for in-vitro fertilization (IVF) market is highly competitive and fragmented, with several players operating globally. The prominent players are focusing on providing services per patients' requirements through their research and development activities. Moreover, the market players adopt strategic plans for uplifting the market through partnerships, mergers, and acquisitions.
Other Prominent Players in the Cryopreservation for in-vitro fertilization Market are:
Recent Developments in the Global Cryopreservation for In-vitro Fertilization Market are:
Vitrolife AB: In 2021, Vitrolife acquired the Australian company LifeAire Systems, which develops air purification systems for IVF laboratories. The acquisition is expected to expand Vitrolife's offerings in the IVF market.
Irvine Scientific: In 2020, Irvine Scientific announced the launch of its new vitrification solution, designed to improve embryos' survival rates during the cryopreservation process.
Thermo Fisher Scientific: In 2021, Thermo Fisher Scientific acquired Mesa Biotech, a California-based company that develops diagnostic tests for infectious diseases. The acquisition is expected to strengthen Thermo Fisher's capabilities in the diagnostics market.
CooperSurgical: In 2020, CooperSurgical announced the launch of its new EmbryoScope+ time-lapse incubator, designed to improve the efficiency and accuracy of IVF procedures.
Genea Biomedx: In 2021, Genea Biomedx announced the launch of its new Gavi robotic laser system, designed to improve the accuracy and speed of laser-assisted hatching procedures during IVF.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD billion for Value |
| Key Countries Covered | United States, Canada, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Türkiye, Northern Africa, and South Africa |
| Key Segments Covered | Product, End User, Region |
| Key Companies Profiled | Thermo Fisher Scientific Inc.; Merck KGaA; VWR International, LLC; Avantor, Inc.; Charter Medical Ltd.; BioLife Solutions, Inc.; Cesca Therapeutics Inc.; Worthington Industries, Inc.; Taylor-Wharton International LLC |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
In 2023, the global demand for cryopreservation for IVF could generate USD 461.4 million in revenue.
The global adoption of IVF cryopreservation is poised to witness a 10.6% CAGR through 2033.
The cryopreservation media segment garners higher revenue and is poised to have a 10.5% CAGR until 2033.
The regional market is expected to reach USD 182.7 million by 2033 following an 11.2% CAGR till then.
The overall demand in Europe is poised to be driven by Germany with an 11.6% CAGR through 2033.
1. Executive Summary | Cryopreservation for In-vitro Fertilization (IVF) Market 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Cryopreservation Media 5.2. Cryopreservation Storage Devices 5.2.1. Dewars 5.2.2. Cryogenic Liquid Cylinders 5.2.3. Cryogenic Storage Tanks 5.2.4. Storage Container 5.3. Consumables & Accessories 5.3.1. Vitrification Carriers 5.3.2. Sperm Straws 5.3.3. Saw Freeze Straws 5.3.4. Cryovials 5.4. Cryo-Shipping 5.4.1. Dry Shipper Container 5.4.2. Clinical Pack Over Wrap 5.4.3. Cryogenic Labels 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Oocyte Cryopreservation 6.2. Sperm Cryopreservation 6.3. Embryo Cryopreservation 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Biobanks 7.2. IVF & Fertility Clinics 7.3. Research & Academic Institutes 7.4. Cryo-shipping/couriers 7.5. Cryo Monitoring /Inventory Management 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Europe 8.4. South Asia 8.5. East Asia 8.6. Oceania 8.7. Middle East and Africa 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Thermo Fisher Scientific Inc. 18.2. Millipore Sigma 18.3. FUJIFILM Irvine Scientific 18.4. Vitrolife AB 18.5. KITAZATO CORPORATION 18.6. Brooks Life Sciences 18.7. Corning Inc. 18.8. Worthington Industries Inc. 18.9. Cook Medical LLC 18.10. Bio-Math Tech Ltd 18.11. Cryo Solutions B.V. 18.12. Cryogatt Systems Ltd. 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Cryopreservation for In-vitro Fertilization (IVF) Market
